Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Waeber

Showing results (31-40 of 458) with videos related to

Pageof 46
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1996
Do we need new antihypertensive drugs?H R Brunner, B Waeber
Blood Pressure Monitoring|November 5, 1999
Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapyB Waeber, H R Brunner
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1995
Main objectives and new aspects of combination treatment of hypertensionB Waeber, H R Brunner
Journal of Cardiovascular Pharmacology|January 1, 1996
Cardiovascular hypertrophy: role of angiotensin II and bradykininB Waeber, H R Brunner
Revue Medicale Suisse|February 9, 2006
[Understanding Raynaud's phenomenon: towards a better treatment]P A Bart, B Waeber
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Rationale for the use of very-low-dose combinations as first-line treatment of hypertensionB Waeber, H R Brunner
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 22, 1998
[Measurement of blood pressure: best way to assess cardiovascular risk?]B Waeber, H R Brunner
The British Journal of Clinical Practice|July 1, 1996
Angiotensin II antagonists: a new class of antihypertensive agentB Waeber, H R Brunner
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 21, 2001
The multifactorial nature of hypertension: the greatest challenge for its treatment?B Waeber, H R Brunner, , et al.
Praxis|May 11, 2000
[Evidence-based medicine in routine clinical practice]B Waeber, A Pechère-Bertschi
Pageof 46

Showing results (31-40 of 458) with videos related to

Sort By:
Pageof 46
Journal of Cardiovascular Pharmacology|January 1, 1996
Do we need new antihypertensive drugs?H R Brunner, B Waeber
Blood Pressure Monitoring|November 5, 1999
Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapyB Waeber, H R Brunner
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1995
Main objectives and new aspects of combination treatment of hypertensionB Waeber, H R Brunner
Journal of Cardiovascular Pharmacology|January 1, 1996
Cardiovascular hypertrophy: role of angiotensin II and bradykininB Waeber, H R Brunner
Revue Medicale Suisse|February 9, 2006
[Understanding Raynaud's phenomenon: towards a better treatment]P A Bart, B Waeber
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Rationale for the use of very-low-dose combinations as first-line treatment of hypertensionB Waeber, H R Brunner
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 22, 1998
[Measurement of blood pressure: best way to assess cardiovascular risk?]B Waeber, H R Brunner
The British Journal of Clinical Practice|July 1, 1996
Angiotensin II antagonists: a new class of antihypertensive agentB Waeber, H R Brunner
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 21, 2001
The multifactorial nature of hypertension: the greatest challenge for its treatment?B Waeber, H R Brunner, , et al.
Praxis|May 11, 2000
[Evidence-based medicine in routine clinical practice]B Waeber, A Pechère-Bertschi
Pageof 46